Paediatric facial paralysis: An overview and insights into management

Mohammad Malik1, Jonathan J Cubitt1

  • 1The Welsh Centre of Burns and Plastic Surgery, Morriston Hospital, Swansea, United Kingdom.

Insights

Paediatric facial paralysis, affecting children

Area of Science:

  • Pediatric Neurology
  • Otolaryngology
  • Facial Surgery

Background:

  • Facial paralysis involves the inability to control facial expression muscles.
  • Incidence rates vary by age: 2.7/100,000 for under 10s and 10.1/100,000 for over 10s annually.
  • Causes are diverse, influencing prognosis and treatment.

Purpose of the Study:

  • To offer a comprehensive overview of pediatric facial paralysis.
  • To cover etiology, epidemiology, diagnostic approaches, and treatment strategies.

Main Methods:

  • Literature review and synthesis of existing research on pediatric facial paralysis.
  • Analysis of epidemiological data, diagnostic workups, and therapeutic interventions.

Main Results:

  • Corticosteroids and facial therapy are primary treatments.
  • Surgical intervention is considered for persistent cases to enhance symmetry, protect eyesight, and restore movement.

Conclusions:

  • Effective management of pediatric facial paralysis requires understanding its varied causes.
  • Treatment plans, including medical and surgical options, should be individualized to optimize outcomes.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.2K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
376
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
253
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
359
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
237